PRIAPISM
Clinical trials for PRIAPISM explained in plain language.
Never miss a new study
Get alerted when new PRIAPISM trials appear
Sign up with your email to follow new studies for PRIAPISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sickle cell patients: drug may curb debilitating erections
Disease control CompletedThis study tested a drug called crizanlizumab in 36 men with sickle cell disease who suffer from priapism—painful, unwanted erections lasting an hour or more. The goal was to see if the drug could reduce how often these episodes happen over 26 weeks. Participants reported their e…
Matched conditions: PRIAPISM
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Rat study tests antioxidant for erection injury
Knowledge-focused CompletedThis study looked at whether alpha lipoic acid, a natural antioxidant, can reduce tissue damage when blood flow returns after a prolonged, painful erection (priapism) in rats. Researchers divided 18 rats into groups and measured markers of oxidative stress and inflammation in the…
Matched conditions: PRIAPISM
Phase: NA • Sponsor: Trabzon Kanuni Education and Research Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC